Analysts Have Conflicting Sentiments on These Healthcare Companies: OptimizeRx (OPRX), Immunocore Holdings (IMCR) and Acadia Healthcare (ACHC)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on OptimizeRx (OPRX – Research Report), Immunocore Holdings (IMCR – Research Report) and Acadia Healthcare (ACHC – Research Report).

OptimizeRx (OPRX)

Barclays analyst Stephanie Davis maintained a Hold rating on OptimizeRx today and set a price target of $15.00. The company’s shares closed last Tuesday at $10.48.

According to TipRanks.com, Davis is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -7.2% and a 40.0% success rate. Davis covers the Healthcare sector, focusing on stocks such as Walgreens Boots Alliance, Lifestance Health Group, and Quest Diagnostics.

Currently, the analyst consensus on OptimizeRx is a Strong Buy with an average price target of $16.33.

See the top stocks recommended by analysts >>

Immunocore Holdings (IMCR)

In a report released today, Peter Lawson from Barclays maintained a Buy rating on Immunocore Holdings, with a price target of $92.00. The company’s shares closed last Tuesday at $55.85.

According to TipRanks.com, Lawson is a 4-star analyst with an average return of 4.4% and a 43.8% success rate. Lawson covers the Healthcare sector, focusing on stocks such as Deciphera Pharmaceuticals, Springworks Therapeutics, and Adaptimmune Therapeutics.

Immunocore Holdings has an analyst consensus of Strong Buy, with a price target consensus of $84.42, a 48.1% upside from current levels. In a report issued on May 8, Needham also maintained a Buy rating on the stock with a $81.00 price target.

Acadia Healthcare (ACHC)

Barclays analyst Andrew Mok CFA maintained a Buy rating on Acadia Healthcare today and set a price target of $89.00. The company’s shares closed last Tuesday at $71.32.

According to TipRanks.com, CFA is a 1-star analyst with an average return of -3.7% and a 49.0% success rate. CFA covers the Healthcare sector, focusing on stocks such as Alignment Healthcare, Privia Health Group, and Molina Healthcare.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Acadia Healthcare with a $88.50 average price target, a 22.2% upside from current levels. In a report issued on May 1, Leerink Partners also reiterated a Buy rating on the stock with a $89.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on OPRX:

• OptimizeRx to Participate in Upcoming Investor Conferences 
• OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET
• OptimizeRx sees Q1 revenue $18.5M-$19.2M, consensus $17.03M
• OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
• Navigating New Horizons: Optimizerx Corporation’s Strategic Pivot Raises Financial Risk Flags